Mangoceuticals Inc.
13F holders, Q3 2024 (September 30)12holders +6
10new positions
4sold out
$0.24avg. 13F price*
At the end of Q3 2024, 12 institutions reported holding Mangoceuticals Inc. in their 13F filings, up 6 from Q2 2024. 10 opened new positions and 4 sold out. The largest holders were Ackerman Capital Advisors, LLC ($206K), Geode Capital Management, LLC ($31K) and PEAK6 Investments LLC ($21K).
- Company
- Mangoceuticals Inc.
- CUSIP
- 56270V106
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $291K |
| Exits | 4 | $91K |
All 13F filers, Q2 2024 → Q3 2024: 1,232,548 shares bought and 376,446 shares sold, net +856,102 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Ackerman Capital Advisors, LLC | 0.05% | New | 873,356 | $206K |
| Geode Capital Management, LLC | 0.00% | New | 131,327 | $31K |
| PEAK6 Investments LLC | 0.00% | Reduce -0.1% | 88,258 | $21K |
| McCollum Christoferson Group LLC | 0.01% | New | 85,800 | $20K |
| Two Sigma Securities, LLC | 0.00% | New | 37,845 | $9K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 31,400 | $7K |
| XTX Topco Ltd | 0.00% | New | 28,830 | $7K |
| Creative Planning | 0.00% | New | 20,000 | $5K |
| Virtu Financial LLC | 0.00% | Reduce -80.9% | 18,839 | $4K |
| StoneX Group Inc. | 0.00% | New | 13,647 | $3K |
| Goldman Sachs Group Inc. | 0.00% | New | 10,187 | $2K |
| Bank of America Corp. | 0.00% | New | 156 | $37 |
"% of holder's portfolio" is MANGOCEUTICALS INC's weight in each manager's 13F, not the share of Mangoceuticals Inc. the manager owns.